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Objectives: Investments in health research should lead to improvements in health and
health care. This is also the remit of the main HTA program in the Netherlands. The aims
of this study were to assess whether the results of this program have led to such
improvements and to analyze how best to assess the impact from health
research.
Methods: We assessed the impact of individual HTA projects by adapting the “payback
framework” developed in the United Kingdom. We conducted dossier reviews and sent a
survey to principal investigators of forty-three projects awarded between 2000 and 2003.
We then provided an overview of documented output and outcome that was assessed by
ten HTA experts using a scoring method. Finally, we conducted five case studies using
information from additional dossier review and semistructured key informant interviews.
Results: The findings confirm that the payback framework is a useful approach to assess
the impact of HTA projects. We identified over 101 peer reviewed papers, more than
twenty-five PhDs, citations of research in guidelines (six projects), and implementation of
new treatment strategies (eleven projects). The case studies provided greater depth and
understanding about the levels of impact that arise and why and how they have been
achieved.
Conclusions: It is generally too early to determine whether the HTA program led to actual
changes in healthcare policy and practice. However, the results can be used as a baseline
measurement for future evaluation and can help funding organizations or HTA agencies
consider how to assess impact, possibly routinely. This, in turn, could help inform
research strategies and justify expenditure for health research.
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Assessing the returns from research is of increasing interest
to research-funding organizations (1;6;10;11;13–16). From
an international perspective health services are increasingly
emphasizing the need to ensure that health care is evidence-
based. For those involved in healthcare-related research, in-
cluding health technology assessment (HTA), the focus lies
on providing a strong and robust research foundation and fa-
cilitating the translation of research into practice, so ensuring
that investments in health research lead to improvements in
health and health care. Such improvements are the remit of
the main HTA program in the Netherlands.
This Health Care Efficiency Research program is coor-
dinated by the Netherlands organization for health research
and development (ZonMw). The program actively promotes
research on the recognition, assessment, and implementation
of cost-effective interventions and fosters generalization of
knowledge with an annual budget of 12.2 million Euro.
In 2000, the program was implemented and commis-
sioned by the Dutch Minister of Health, Welfare, and Sport.
In 2001, the first grants for this program were allocated.
There are two main ways to support research within this
HTA program:
• Bottom-Up: In 2001, the Ministry did not specify priorities and an
open submission of research proposals resulted. The second round
(2002) was a so-called “steered bottom-up approach,” which
means that, in the event of equal scientific quality, preference
was given to priority areas defined by the Ministry of Health,
Welfare, and Sport. The priority areas were detection of cancer
metastases, mental and behavioral disorders, care of chronically
ill, clinical genetics, and infectious diseases.
• Top-Down: The focus was on two predefined subjects: positron
emission tomography (PET) diagnostics and treatment of fertility
disorders in the rounds 2001 and 2002. Almost all applications
come from academic hospitals, and many involve randomized
clinical trials (RCTs) concerning therapeutic or diagnostic proce-
dures (17;18).
Whether the results of this program have actually led to
improvements in health and health care has never been re-
searched in a systematic way. With this study, we aim to con-
tribute to the systematic analysis of the Dutch HTA program
by applying a model to assess impact based on the output and
outcome of individual HTA projects. We based our approach
on a method implemented by HERG, Brunel University, and
the Wessex Institute, University of Southampton to assess
the payback of HTA projects in the United Kingdom (8). The
study described here was also intended to test if and how the
“payback framework” might prove useful in reviewing the
payback of HTA projects in the Netherlands.
METHODS
Development of Evaluation Framework
We developed an evaluation framework to assess payback of
individual HTA projects on the basis of desk research. Mem-
bers of our research team (Brunel University) have been
examining how to conceptualize, describe, and assess the
“payback” of funded research since 1993. It is important to
acknowledge that this is broader than an assessment of the
scientific quality of research per se; the impact of research is
the key issue. This has resulted in the payback framework that
consists of a conceptual categorization of the benefits aris-
ing from health services research and a model for assessing
“payback” (2;3;10).
The evaluation framework we used consists of two com-
ponents: (i) A logic model of the research process. Logic
models are widely used in evaluation methodology to un-
derstand input-process-output relationships and breakdown
research programs into parts. The payback model developed
by Buxton and Hanney is an example of a logic model and
breaks down the process by which (HTA) research is trans-
lated into practice, and provides a way to organize the as-
sessment of this multidimensional categorization of benefits
from research (Figure 1).
(ii) The definition of evaluation criteria for output and
outcome of funded research. We slightly adapted the origi-
nal payback criteria of the payback framework and used the
following categories: Knowledge Production (e.g., number
of publications), Research Benefits (e.g., development of re-
search skills, personnel and capacity), Informing Policy (e.g.,
development of new treatment guidelines), Changing Health
Practice (e.g., use of new treatment strategies), and Broader
Impact on Health (e.g., economic benefits from a healthy
workforce). It was recognized in advance by the research
team that it would be difficult to obtain “hard” data for last
two criteria due to the fact that the HTA program had only
started in 2000.
Dossier Review
Guided by the framework, two researchers conducted dossier
reviews of all forty-three projects granted between 2001 and
2003. Most projects took the form of prospective, clinical tri-
als (two-third of the grants), while others, for example, were
modeling studies (18). We read the key documents including
the original research grant proposals, referees reports, final
reports, and information about the program (annual reports,
minutes of committee meetings, and so on). We collected and
synthesized the information from the dossiers at ZonMw.
Postal Survey
In parallel, we developed a survey that was based on a (postal)
questionnaire that Buxton et al. (4) developed, subsequently
refined, and also used for assessing the impact of the UK
Department of Health HTA Program (8;9). The relevance
of the survey to the particular context was tested by an
international HTA researcher, who has experience as a re-
viewer of the ZonMw grants. We sent the postal survey,
including data from the dossier review, to all principal in-
vestigators to collect the most recent data on their projects.
It might have been a good idea to conduct a separate user
survey had the resources for the study been much greater.
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Figure 1. Schematic diagram of the payback model.
The model serves to indicate a series of stages that help to organize payback assessments:
Stage 0: Topic/Issue Identification involves the generation of the original ideas for the research; Interface A: Project Specification
and Selection involves the development of research proposals and the (peer) review process;
Stage 1: Inputs to research focus on financial inputs, but also expertise of the research team and knowledge base of the
research team;
Stage 2: Research Processes concern how the research was conducted and any difficulties encountered in patient inclusion,
appropriateness of methods, involvement of potential users, and so on;
Stage 3: Primary Outputs from Research relate to knowledge production, mainly publications; Interface B: Dissemination
reflects the procedure at the end of a study whereby the findings are disseminated to the policymakers and more widely (e.g.,
by presentations);
Stage 4: Secondary Outputs includes a wide variety of items such as reimbursement decisions by the Ministry of Health; citing
of the findings in a clinical guideline from a national or local professional group; or inclusion of the findings in a contract or in a
document from an audit, an inspectorate or an evaluative body;
Stage 5: Adoption by Practitioners and Public deals with behavioral change that is necessary to implement the findings of
the research into practice to result in final outcomes. Examples are adoption of a new surgical technique that appeared to be
cost-effective or introduction of a new pharmaceutical on the market;
Stage 6: Final Outcomes are seen as the ultimate goal of the research. For health research this goal involves improved public
health (or quality of life) and broader economic benefits.
Source: (10).
On the basis of the survey data, a first inventory of the
outputs and outcomes of the HTA projects was made. The
results were presented as a summary; that is, one page stan-
dard form about the payback from each HTA study. Using a
common structure for all research grants has the advantage of
facilitating comparative analysis, allowing us, for example,
to identify the factors associated with successful translation
of research.
Case Study Analysis
To provide a deeper understanding of how payback occurs,
a purposive sample of five HTA projects were investigated
in more detail to illustrate useful levels of payback. With
the help of the Committee for Health Care Efficiency Re-
search (CDO), we selected for case studies five projects that
mirrored the diversity of ZonMw funding. We developed a
semistructured interview protocol based upon the protocol
used in a previous research impact study (16). In each case
study, we explored the initial and longer-term output and out-
come of the research in more detail, including the translation
of the research (e.g., into practice). We planned to under-
take three interviews per case study (either face-to-face or
by telephone) including users, the principal investigator, and
at least one other involved researcher. In total, we conducted
fourteen interviews lasting between 45 and 90 minutes. The
interview aimed to verify conclusions from written materials
and to identify any payback that might have been missed. In
all cases, the interviews were used to update the information
retrieved from desk research. Using the information collected
from a more in-depth dossier review and semistructured key
informant interviews, each of the five cases was written up
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as a narrative organized according to the structure provided
by the payback model.
Scoring of Payback Using HTA Experts
The scoring of payback is an attempt to standardize the find-
ings from the data gathered with the aim that this will al-
low comparisons to be made, for example, between different
modes of funding HTA projects. To allow such comparisons
to be drawn, it was important to include a sufficient number
of HTA projects in the scoring exercise. Previous experience
of applying the payback framework suggested that at least
18–24 months should elapse between the end of a study and
the main payback assessment. This was indeed confirmed
by our study, but most of the projects in the Dutch HTA
program had not yet reached this time-scale. To generate a
sufficient number of projects we, therefore, had to include
all the projects that had already led to a final report and for
which we had received survey results, even if they had been
completed only a short time before the payback assessment
was conducted. From the total number of grants (n = 43),
twenty-six met these two criteria.
The outputs and outcomes of these projects were then
reviewed by ten HTA experts, including representatives of pa-
tient organizations, health insurers, ministry of Health, health
advisory councils, CDO, the Committee for the Evaluation
of the Scientific Quality, and health professional bodies. For
this purpose, we developed a novel method of scoring the
projects in terms of payback that consisted of three rounds
of scoring:
First Round Scoring
Information resulting from dossier review and the survey
results was used for writing summaries of the impact from
the twenty-six HTA projects. We invited sixteen experts to
participate in the scoring exercise of which eleven experts
indicated their willingness to participate in the study. The
experts were asked (by mail) to score the impact of each
study based on these summaries and using a scoring sys-
tem based on those that had been used in previous payback
studies (8;16). It provided a method for converting the quali-
tative descriptions of the payback in each of the payback
categories into a quantitative measure. These rating forms
were sent—together with scoring instructions—to each ex-
pert, after having tested them by two members of the research
team. The experts were asked to score each HTA study for
all payback categories on a scale ranging from 0 to 10. At
the bottom of the scale, 0 represented no payback. At the top
end of the scale the value of 10 was a qualitative description
of the largest payback in that category that could have been
expected (Table 1).
The rating forms of ten experts were returned by post
and quantitatively analyzed. It is important to emphasize that
the last three scoring categories (Informing Policy, Changing
Health Practice, and Broader Impact on Health) differ in a
major way from the first two categories (Knowledge Produc-
tion and Research Benefits) in the sense that the a) and b)
scales are related in a different way. In Knowledge Produc-
tion and Research Benefits, the a) and b) scales cover issues
that can be considered separately, and for them, it makes
sense just to aggregate the scores. For the other scoring cat-
egories, the a) scale in each case covers the scope of the
impact (i.e., nature of the policy level, numbers who ben-
efit), whereas the b) scale covers how far the research was
responsible. Thus, the combined score for each of these last
three categories should be the product of the a) and b) scores
(i.e., a × b) not the summation (i.e. a + b) because of their
nature (“level” and “degree” of impact) (4). Because of this,
we cannot add the ten scores of each project to determine
the final payback of each project. We can, however, plot the
summarized scores (adding 1a + 1b, 2a + b and multiplying
3a × 3b, 4a × 4b and 5a × 5b) on a spider plot whose size
and shape represents the payback from the HTA study.
The scores from the first round were analyzed and sheets
showing their distribution were circulated to the experts be-
fore an expert meeting (second round scoring). As was done
in Wooding et al. (16), we used the RAND/UCLA (Univer-
sity of California at Los Angeles) Appropriateness Method
(RAM) for analyzing levels of disagreement and agreement
between experts (consistency) (7). The RAM method pro-
vides an algorithm for determining whether disagreement
exists between scorers. However, this method focuses on the
occasions where people are scoring at opposite ends of the
scale. Therefore, in addition to the RAM disagreement algo-
rithm we also tested disagreement by checking whether the
actual score was more than two or three points from the me-
dian score, as was also done in a former impact study (16). To
select five HTA projects to be re-scored during the half-day
meeting, we used a figure that captures disagreement with
regard to the HTA study as a whole. For this purpose, we
selected projects with the largest variance of scores, being
the sum of the variances of the ten scoring items (criteria).
Second Round Scoring
Nine of eleven experts who were willing to participate in the
study were brought together at a meeting to give them the
opportunity to discuss the scoring face-to-face, in light of the
knowledge of their collective responses and to resolve any
misunderstandings about the outputs from the summaries.
Each expert was given scoring sheets showing his/her score
and the distribution of scores for each criterion and the av-
erage score per criterion. At the meeting, we discussed the
scoring of the projects which exhibited the largest scoring
variance and the arguments used for scoring. We were not
necessarily seeking consensus—the expert meeting allowed
experts to understand the reasoning that lay behind diver-
gent views. During the expert meeting, we also discussed the
methodological approach used. At the end of the discussion,
the experts had the opportunity to re-score the projects to
determine the areas of final agreement and disagreement.
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Table 1. Scoring Scales Payback Categories
KNOWLEDGE PRODUCTION
1a. Presentations
We would like you to consider the number of presentations to international, national or local meetings, where a full presentation is
generally ranked higher than poster presentations.
10 – At least 6 presentations made to international conferences.
8 – At least 3 presentations made to international conferences, or more than 6 presentations made to national meetings.
6 – At least 1 presentation made to an international conference, or more than 3 presentations made to national meetings.
4 – More than 1 conference poster or external presentation made, for example to a practitioner, patient, or research group (including
continuous medical education).
2 – At least 1 conference poster or external presentation made, for example to a practitioner, patient, or research group (including
continuous medical education).
0 – No presentations or posters.
1b. Publications
We would like you to consider those publications that contribute to knowledge dissemination; thus, this suggests a judgment of the
impact factor and quality of the journals.
10 – The project produced at least 8 peer-reviewed publications (not abstracts or conference proceedings) in respected journals.
8 – The project produced at least 5 peer-reviewed publications (not abstracts or conference proceedings) in respected journals.
6 – The project produced at least 3 peer-reviewed publications (not abstracts or conference proceedings) in respected journals.
4 – The project produced at least 1 peer-reviewed publication (not abstracts or conference proceedings) in a respected journal or a
journal relevant for the target audience (not abstracts or conference proceedings), e.g., in a (inter)national professional journal.
2 – The project produced internal (e.g., report of department) but no external publications.
0 – The project produced no publications or internal report.
RESEARCH BENEFITS
2a. Capacity building
We would like you to consider the development of research skills, personnel and research capacity, e.g., training of health
professionals involved in the research.
10 – The project made a considerable contribution to at least 2 research degrees, such as PhDs.
8 – The project either made a considerable contribution to at least 1 research degree, or a moderate contribution to at least 2.
6 – The project made a moderate contribution to at least 1 research degree.
4 – The project made some contribution to at least 1 research degree.
2 – The project some contribution to research capacity building in some other way (e.g., training of specific tasks).
0 – The project made no contribution to research degrees or research capacity building in any other way.
2b. Research targeting
We would like you to consider a variety of contributions to follow-on research: pilot studies, implementation projects, methodological
frameworks, or mathematical underpinnings, and so on (absorption of knowledge, including from abroad).
10 – The project made a considerable contribution to more than 1 follow-on project by the team and/or by others.
8 – The project made a contribution to more than 1 follow-on project, considerable in at least one case.
6 – The project made a contribution to more than 1 follow-on project, moderate in at least one case.
4 – The project made a moderate contribution to 1 follow-on project, or any contribution to more than one follow-on project.
2 – The project made a contribution to at least 1 follow-on project.
0 – The project made no contribution to targeting of future research.
INFORMING POLICY
We would like you to consider policy making at (inter)national or local level of the health system, e.g., reimbursement decisions by
the Ministry of Health, citing of the findings in an advice of the Health Council, citing of the findings in a clinical guideline from a
national or local professional group, inclusion of the findings in a contract or in a document from an audit, an inspectorial or an
evaluative body).
3a. Nature of the policy (e.g., reimbursement decisions, use in clinical guidelines)
10 – The project made an impact on a substantial policy of an international body or substantial policies of at least the national
government.
8 – The project made an impact on at least 1 policy (brief) from a national body such as the Health Council (GR), Council for Health
Research (RGO).
6 – The project made an impact on at least 1 policy from a national professional body.
4 – The project made an impact on the policymaking of at least 1 local unit of the health service.
2 – A claim for impact was made but no details given, or details given of a claim for expected future impacts.
0 – The project made no impact on policies.
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Table 1. Continued.
3b. Degree of impact on health policy
10 – At least 1 of the policies was almost solely based on the project’s evidence in a direct instrumental way.
8 – The project made a considerable impact on the policy/policies.
6 – The project made a moderate impact on the policy/policies in an instrumental way, or made an important contribution at a
conceptual level to the policy/policies discussions.
4 – The project made some identifiable impact on the policy/policies.
2 – A claim for impact was made but no details given, or details given of a claim for expected future impacts.
0 – No impact on policy making.
CHANGING HEALTH PRACTICE
We would like you to consider application of the findings by health practitioners on (inter)national or local level, such as the
application of policies, changed behavior of practitioners and managers, the involvement of consumers/patients.
4a. Level of impact in health practice
10 – The project made an impact on behavior in more than 1 country.
8 – The project made an impact on behavior at national level.
6 – The project made an impact on the behavior of at least 1 team of practitioners or managers, or at least 1 group of patients/
members of the wider public.
4 – The project made an impact on behavior of at least 1 or more practitioner, manager, patient, or member of the public.
2 – A claim for impact made but no details given, or details given of a claim for expected future impacts.
0 – The project made no impact on behavior.
4b. Degree of impact in health practice
10 – At least 1 of the changed behavior(s) was almost solely based on the project’s evidence in a direct instrumental way.
8 – The project made a considerable impact on the behavior(s).
6 – The project made a moderate impact on the behavior(s).
4 – The project made some identifiable impact on the behavior(s).
2 – A claim for impact made but no details given, or details given of a claim for expected future impacts.
0 – No impact on behavior.
BROADER IMPACT ON HEALTH
We would like you to consider the broader (societal) impact on health benefits, e.g., health gains, improved efficiency/cost reduction
in the delivery of existing services, qualitative improvements in service delivery; improved allocation of resources at an area level,
improved accessibility (e.g., improved geographical accessibility, improved equity of access on a gender or ethnic basis).
5a. Level of health benefits
10 – The project led to very large health benefits (in terms of a substantial health gain for many people, and/or major cost reductions,
and so on).
8 – The project led to considerable benefits (in terms of the amount of health gain, the numbers involved, and/or cost reductions, and
so on).
6 – The project led to moderate health benefits (in terms of the amount of health gain, the numbers involved, and/or cost reductions,
and so on).
4 – The project led to some health benefits (in terms of some health gain for some people, and/or some cost reduction, and so on).
2 – A claim for impact made but no details given.
0 – The project made no impact on health/health sector.
5b. Degree of impact on health benefits
10 – At least one of the health benefits was almost solely based on the project’s evidence in a direct instrumental way.
8 – The project made a considerable impact on the health benefits.
6 – The project made a moderate impact on the health benefits.
4 – The project made some identifiable impact on the health benefits.
2 – A claim for impact made but no details given, or details given of a claim for expected future impacts.
0 – No impact on health benefits.
Third Round Scoring
The detailed case studies were then sent to the HTA ex-
perts for re-scoring of the payback categories based on this
fuller information now available. The experts were not pro-
vided with their initial scores, although they may have re-
membered them or recorded them themselves. These third-
round scores were then compared with their individual sec-
ond round scores. This comparison provided an indication
of the influence of more detailed information on scoring of
payback.
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RESULTS
Output of HTA Projects
The findings show that the payback framework is a promising
approach to assess the impact of HTA projects. We received
thirty-four of forty-three surveys (response rate: 79 percent).
In total, we identified over 101 peer reviewed papers; more
than twenty-five PhD dissertations; citations of research in
guidelines were mentioned in six projects; and implemen-
tation of new treatment strategies were described in eleven
projects. The research payback of all thirty-four HTA projects
is summarized (per subsidy round) in Table 2 below.
Scoring Impact
The HTA experts scored those HTA projects that had already
led to a final report and for which we had received survey
results (n = 26). All HTA experts used the payback categories
and related scales (Table 1) at their disposal; they were not
hesitant to score high or low (the average score given by the
experts was 4.3). We could possibly, therefore, deduce that
the descriptions of the scoring scales did not constrain the
scoring range.
With regard to disagreement between the HTA experts in
scoring, we conclude that whatever method of determining
disagreement is used, most contention exists for the scor-
ing items of scoring categories 3 to 5 (Informing Policy,
Changing Health Practice, and Broader Impact on Health)
(Table 3).
The participants at the expert meeting did not make much
use of the possibility to re-score projects at the end of the
meeting. Four out of nine participants changed their scores
(for more than one study). In general, scores were adjusted
to a lower score (dismissing claims of expected outcome),
but also some higher scores were given. The re-scoring did
reduce the variance around the scores for some projects. A
preliminary conclusion is that discussing the projects in an
expert meeting may lead to greater consensus. However, it
would have been necessary to have discussed and rescored all
projects, including those which initially had little variance,
to be sure about this conclusion.
Analysis Based on the Scoring of the
Impact of HTA Projects
Once the score (per payback category) per study has been
calculated, a comparison can be made between the different
subsidy rounds of the HTA program. For this, we averaged the
scores per category per round (shown in Figure 2). This plot
shows that, for all the five scoring categories, the average
scores for each subsidy round remain quite close to each
other.
Specific HTA projects can, however, potentially influ-
ence the scoring drastically. One clear example involves the
PET subsidy round, which scored significantly less on both
the Knowledge Production as well as the Research Bene-
fits categories. Before attempting to explain this difference,
we should realize that the average is based on small num-
bers; therefore, chance findings can easily occur. However,
even when removing the project in this group that scored ex-
tremely low because of its early termination, the difference
with the other projects remains.
Figure 2. Average score per subsidy round, first scoring. KP, Knowledge Production; RTCB, Research Benefits; IP, Informing
Policy; CHP, Changing Health Practice; BH, Broader Impact on Health.
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Table 2. Summary of Research Payback of the Subsidy Rounds Considered
Subsidy round Knowledge production Research benefits Informing policy Changes in health practice Broader impact on health
Bottom-up 2001
(N = 6/9
projects)
32 peer reviewed articles and
20 other publications (such
as published abstracts,
thesis and chapter in book).
75 presentations of which 21
international full
presentations. The main
audiences were academia
and health professionals
(e.g., psychiatrists and
mental health workers).
Three projects resulted in 5
future projects of which
one was a follow-on
activity supported by
ZonMw (total budget of
270,000 Euro).
In total, 9 researchers
obtained their PhD
(resulting from 5 projects).
Also, one project resulted
in scientific training for
medical students.
Informing actual policy was
only mentioned by 2
projects. Considering the
objectives of the DO
program, informing policy
is expected for almost all
projects. However, there
was little or no evidence of
such impact available.
One of the 6 DO projects has
led to a revision of a
guideline.
Overall impact on health
practice was regarded as
considerable in 4 projects
(e.g., change of treatment
strategies).
In 5 projects considerable
changes in health practice
were expected, but often no
evidence for expected
changes was provided.
In 2 projects broader impact
on health was regarded as
moderate or considerable
(e.g., reduced risk and
patient burden for
diagnostic imaging tests for
peripheral arterial disease).
Generally there was a lack of
evidence for broader
impact on health.
Top-down 2001
(N = 2/3
projects)
6 peer reviewed articles; 5
other publications (such as
journal editorial, published
abstract, and thesis).
18 presentations of which 7
international full
presentations. The main
audiences were academia
and health professionals.
One of the projects led to
further research that is
performed in Belgium. In
addition, the research team
of this project appeared to
be involved in writing a
protocol for an
international study.
In one project a researcher
has obtained his/her PhD in
2004. The other project is
expected to provide a
researcher with his/her PhD
in 2007.
The results of both projects
led to informing policy
(e.g., by organizing
international workshops on
lower rectal cancer) and are
expected to inform policy
in the future (e.g., imaging
of a rectal tumor before
treatment will become
mandatory and will be
included in treatment
protocols).
The results of one project led
to the implementation of a
new treatment strategy,
which has become routine
practice in several hospitals
(i.e. use of less
mediastinoscopies and
thoracotomies in staging
patients with lung cancer).
The other project is
expected to change primary
treatment of rectal cancer
patients by routinely
scanning the liver.
Both projects expect to have
an impact on health (e.g.,
improving the outcome of
treatment for rectal cancer
and less invasive techniques
for staging of lung cancer
will be more convenient for
patients). However, no
evidence on broader impact
on health was provided.
Bottom-up 2002
(N = 13/18
projects)
33 peer reviewed articles; 42
other publications (such as
published abstracts,
newspaper articles and
non-peer reviewed articles).
97 presentations of which 52
international full
presentations. The main
audiences were academia,
health professionals and
health users.
5 PhDs and one professorship
have resulted and 12 PhDs
are intended to result from
the bottom-up projects.
13 follow-on projects totaling
approximately 5 million
Euro are related to these
DO projects. Several
follow-on activities (N = 4)
are funded by ZonMw, but
also by international funds
such as the European
Union. In addition, 2
projects resulted in
contributions to
(international) research
teams.
2 projects have already been
informing policy (e.g., a
financial agreement with a
local health insurer was
made to introduce in vitro
fertilization in manipulated
natural cycles, development
of guidelines for detection
of hereditary colorectal
cancer).
Five other projects are
expected to informing
policy (e.g., affecting
guidelines and hospital
policy regarding spine
fractures and an integrated
diagnostic facility for
psycho-geriatric patients).
In general, the results show
that it is too early to tell
whether the projects have
changed practice.
However, some examples
presented were: change of
IVF treatment practice in a
few hospitals; and increase
of referrals of children with
anxiety disorders to
individual cognitive
behavioral therapy.
Generally there was a lack of
evidence for broader
impact on health.
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Infertility
disorders
(VBS) (N =
6/6 projects)
20 peer reviewed articles; 17
other publications (e.g.,
journal letters, conference
proceedings, and
non-peer-reviewed
articles).
61 presentations of which 24
international full
presentations.
The main audience was
academia and to a lesser
extent health professionals.
3 projects contributed to 3
follow-on projects. ZonMw
funded two of these
projects (approximately
750.000 Euro in total).
These projects have (partly)
contributed to 4 PhDs and
will (partly) result in 9
other PhDs during the
coming 3 years.
The research team of one
project has also contributed
to establishing a network of
collaborative fertility
physicians.
In general, the results show
that it is too early to tell
whether the projects have
informed policy.
In 2 projects it was mentioned
that the results were used in
revising an existing
guideline and
implementing a guideline.
All projects are expecting to
inform policy, e.g., by
citing the findings in
clinical guidelines, and by
revising the current
reimbursement system (per
cycle).
In general, the results show
that it is too early to tell
whether the projects have
changed practice.
However, the results of 2
projects have been used in
the implementation of a
different treatment strategy
in several hospitals.
Some projects expected to
change health practice, e.g.,
by limiting IVF treatment
to couples with a clear
diagnosis of infertility and
by introduction of a policy
of single embryo transfer.
Generally there was a lack of
evidence for broader
impact on health.
PET diagnostics
(N = 7/7
projects)
10 peer reviewed articles; 14
other publications
(including conference
proceedings, thesis, and
published abstracts).
18 presentations of which 9
international full
presentations. The main
audience was academia.
5 PhDs resulted from 2 PET
projects. In 2007, 1 PhD is
expected to result from
another project.
2 projects resulted in 3
follow-on projects, of
which ZonMw funded one
study (budget unknown).
The results of 2 projects are
used in (drafting)
guidelines (e.g., the
guidelines for
hypopharyngeal cancer).
All projects are expecting to
inform policy, e.g., by
adaptation of guidelines for
use of PET in staging of
esophageal cancer or
developing a guideline for
use of PET for patients
with Non-Hodgkin’s
lymphoma cancer.
There was a lack of evidence
for changes in health
practice. However, in 3
projects it was mentioned
that the results were used in
practice (in a protocol for
detecting unknown primary
tumors, in local guidelines
for patients with head and
neck cell carcinoma and
local implementation of
FDG-PET scan in patients
with colorectal liver
metastases).
All projects expected to
change health practice but
often no evidence was
provided.
Generally there was a lack of
evidence for broader
impact on health. The
project on screening for
distant metastases and
synchronous primary
tumors was an exception -
in this project, the
combination of CT/PET
appeared to be more
effective and cost saving
compared with CT and
PET separately.
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Table 3. Different Measures of Disagreement for Each Payback Criterion
1a 1b 2a 2b 3a 3b 4a 4b 5a 5b
Disagreement
according to
RAM
— — — — 1 (4%) 3 (11%) 5 (19%) 3 (11%) 2 (8%) 3 (11%)
Disagreement
according to 3
or more from
median
6 (3%) 4 (2%) 8 (4%) 21 (11%) 33 (17%) 37 (19%) 31 (16%) 38 (19%) 34 (17%) 29 (15%)
Disagreement
according to 2
or more from
median
23 (12%) 22 (11%) 16 (8%) 45 (23%) 59 (30%) 77 (39%) 65 (33%) 79 (40%) 65 (33%) 66 (33%)
Note. The RAM score (row 1) is measured per project, so the number represents the disagreement out of 26 (projects). The other two scores (row 2 and 3)
represent disagreement among 198 scores (for each of the 10 items, two experts scored only 19 relevant projects). 1a = Presentations; 1b = Publications
(Knowledge Production); 2a = Capacity building; 2b = Research targeting (Research Benefits); 3a = Nature of the policy; 3b = Degree of impact on health
policy (Informing Policy); 4a = Level of impact in health practice; 4b = Degree of impact in health practice (Changing Health Practice); 5a = Level of
health benefits; 5b = Degree of impact on health benefits (Broader Impact on Health).
The case studies, although limited in number, showed
that the more detailed analysis can add greater depth and
understanding about the levels of impact that arise and why
and how they have been achieved. Due to a low response rate
in the third round (we received four to six scores per case
study), the results are not presented here. However, the exer-
cise illustrates a proof of concept that could be pursued when
setting up a systematic research impact evaluation in future.
CONCLUSIONS
The payback framework is a comprehensive method to assess
payback in a systematic way. In the payback framework,
any assessment of the scientific quality of research (e.g.,
journal articles, the training of future researchers, and the
development of careers) is part of the broader assessment of
impact: the societal impact of research is the key issue in the
multidimensional categorization of the benefits from health
research (12).
The findings confirm that the payback framework is a
useful approach to assess the impact of HTA projects. We
were able to identify over 101 peer-reviewed papers, more
than twenty-five PhD dissertations, citations of research
in guidelines (according to six projects), and the imple-
mentation of new treatment strategies was mentioned in
eleven projects. However, we found that assessing the actual
impact of HTA projects too soon after the completion of the
research is problematic and that assessing expected impacts
is difficult. It is probably best to wait at least 3–5 years before
addressing (policy) impact questions, although knowledge
production and research benefits (publications, number of
PhD dissertations, and so on) can be addressed earlier on. To
track and document paybacks on a routine basis, it would be
important to use a database that could be added to over time,
and to return to principal investigators periodically after
they had finished their research to update the information on
paybacks.
On the basis of our findings, we conclude the following.
• In general, the payback framework is applicable to the Dutch
HTA program. We were able to identify a considerable range of
research paybacks. Given this diversity of outcome it is impor-
tant to use an assessment method that captures a broad range
of payback. The payback categories developed in this study
provide a structured basis for any further monitoring or eval-
uation of outputs and outcomes of research funded by the HTA
program.
• It is possible to score HTA projects, but the methodology used for
scoring impact needs to be further developed. The results show
that the methodology used for scoring impact should be refined—
in particular the operationalization of the scoring scales, provi-
sion of sufficient information about the HTA projects and the
scoring exercise itself. Communication to experts and coordina-
tion of experts’ input is, therefore, a key issue. The potential of
payback scoring has recently been promoted in an analysis of
ways to evaluate research in a way that recognizes its value to
users (5).
• Assessing and monitoring payback of related projects may be
most appropriate. The experts of the scoring exercise believed
that changes on the (inter)national level can generally not be
attributed to single HTA projects. Pooling results of HTA projects
in the same research area probably results in a higher impact
compared with the impact of individual projects.
• This study was performed too early to fully assess the impact of
the Dutch HTA program.
We recognized in advance that it would be difficult to
obtain “hard” data for assessing the full impact due to the fact
that the HTA program had only started in 2000. However, at
the expert meeting, its value as a baseline measurement was
underlined. Furthermore, the findings of this study can help
funding organizations consider how to assess impact more
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widely in the future, possibly routinely. This, in turn, could
help inform research strategies and justify expenditure.
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